Reduced Expression of UGT1A1 in Intestines of Humanized UGT1 Mice Via Inactivation of NF-κB Leads to Hyperbilirubinemia
Overview
Affiliations
Background & Aims: Bilirubin is a natural and potent antioxidant that accumulates in the blood of newborn children and leads to physiological jaundice. Breastfed infants have higher serum levels of bilirubin than formula-fed infants and are at risk for bilirubin-induced neurological dysfunction (BIND). Clearance of bilirubin requires the expression of uridine diphosphate glucuronosyltransferase (UGT) 1A1; we investigated its role in the association between breast feeding with jaundice in mice.
Methods: We studied mice in which the original Ugt1 locus was disrupted and replaced with the human UGT1 locus (hUGT1 mice); these mice spontaneously develop neonatal hyperbilirubinemia and BIND. We fed human breast milk or formula to neonatal hUGT1 mice and examined activation of the intestinal xenobiotic receptors pregnane X receptor and constitutive androstane receptor. We also examined inflammatory signaling pathways in mice with disruptions in IκB-kinase-α and IκB kinase-β in the intestinal epithelium.
Results: hUGT1 mice that were fed breast milk developed severe hyperbilirubinemia because of suppression of UGT1A1 in the gastrointestinal tract. Formula-fed hUGT1 mice had lower serum levels of bilirubin, which resulted from induction of UGT1A1 in the gastrointestinal tract. hUGT1/Pxr-null mice did not develop severe hyperbilirubinemia, whereas hUGT1/Car-null mice were susceptible to BIND when they were fed breast milk. Breast milk appeared to suppress intestinal IκB kinase α and β, resulting in inactivation of nuclear factor-κB and loss of expression of UGT1A1, leading to hyperbilirubinemia.
Conclusions: Breast milk reduces expression of intestinal UGT1A1, which leads to hyperbilirubinemia and BIND; suppression of this gene appears to involve inactivation of nuclear factor-κB. Hyperbilirubinemia can be reduced by activation of pregnane X receptor, constitutive androstane receptor, or nuclear factor-κB.
Leskiw E, Whaley A, Hopwood P, Houston T, Murib N, Al-Falih D Genes (Basel). 2024; 15(10).
PMID: 39457450 PMC: 11507559. DOI: 10.3390/genes15101326.
Peng J, Fan M, Huang K, Huang L, Wang Y, Yin R Molecules. 2023; 28(14).
PMID: 37513205 PMC: 10383687. DOI: 10.3390/molecules28145332.
Gao C, Guo Y, Huang M, He J, Qiu X Nutrients. 2023; 15(10).
PMID: 37242142 PMC: 10224501. DOI: 10.3390/nu15102261.
Weber A, Mennillo E, Yang X, van der Schoor L, Jonker J, Chen S Drug Metab Dispos. 2020; 49(1):12-19.
PMID: 33154041 PMC: 7745083. DOI: 10.1124/dmd.120.000240.
Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery.
Wei S, Ma X, Zhao Y Front Pharmacol. 2020; 11:1084.
PMID: 32765278 PMC: 7378542. DOI: 10.3389/fphar.2020.01084.